Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Making sense of big data in health research: Towards an EU action plan

  • Auffray, C.
  • Balling, R.
  • Barroso, I.
  • Bencze, L.
  • Benson, M.
  • Bergeron, J.
  • Bernal-Delgado, E.
  • Blomberg, N.
  • Bock, C.
  • Conesa, A.
  • Del Signore, S.
  • Delogne, C.
  • Devilee, P.
  • Di Meglio, A.
  • Eijkemans, M.
  • Flicek, P.
  • Graf, N.
  • Grimm, V.
  • Guchelaar, H.J
  • Guo, Y.K
  • Gut, I.G.
  • Hanbury, A.
  • Hanif, S.
  • Hilgers, R.D
  • Honrado
  • Hose, D.R.
  • Houwing-Duistermaat, J.
  • Hubbard, T.
  • Janacek, S.H.
  • Karanikas, H.
  • Kievits, T.
  • Kohler, M.
  • Kremer, A.
  • Lanfear, J.
  • Lengauer, T.
  • Maes, E.
  • Meert, T.
  • Müller, W.
  • Nickel, D.
  • Oledzki, P.
  • Pedersen, B.
  • Petkovic, M.
  • Pliakos, K.
  • Rattray, M.
  • i Màs, J.R.
  • Schneider, R.
  • Sengstag, T.
  • Serra-Picamal, X.
  • Spek, W.
  • Vaas, L.A.I.
  • van Batenburg, O.
  • Vandelaer, M.
  • Varnai, P.
  • Villoslada, P.
  • Vizcaíno, J.A.
  • Wubbe, J.P.M.
  • Zanetti, G.
Medicine and healthcare are undergoing profound changes. Whole-genome sequencing and high-resolution imaging technologies are key drivers of this rapid and crucial transformation. Technological innovation combined with automation and miniaturization has triggered an explosion in data production that will soon reach exabyte proportions. How are we going to deal with this exponential increase in data production? The potential of “big data” for improving health is enormous but, at the same time, we face a wide range of challenges to overcome urgently. Europe is very proud of its cultural diversity; however, exploitation of the data made available through advances in genomic medicine, imaging, and a wide range of mobile health applications or connected devices is hampered by numerous historical, technical, legal, and political barriers. European health systems and databases are diverse and fragmented. There is a lack of harmonization of data formats, processing, analysis, and data transfer, which leads to incompatibilities and lost opportunities. Legal frameworks for data sharing are evolving. Clinicians, researchers, and citizens need improved methods, tools, and training to generate, analyze, and query data effectively. Addressing these barriers will contribute to creating the European Single Market for health, which will improve health and healthcare for all Europeans.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Acknowledging the role of patient heterogeneity in hospital outcome reporting: Mortality after acute myocardial infarction in five European countries

  • Comendeiro-Maaløe, M.
  • Estupiñán-Romero, F.
  • Thygesen, L. C.
  • Mateus, C.
  • Merlo, J.
  • Bernal-Delgado, E.
  • behalf of the, ECHO consortium
Background Hospital performance, presented as the comparison of average measurements, dismisses that hospital outcomes may vary across types of patients. We aim at drawing out the relevance of accounting for patient heterogeneity when reporting on hospital performance. Methods An observational study on administrative data from virtually all 2009 hospital admissions for Acute Myocardial Infarction (AMI) discharged in Denmark, Portugal, Slovenia, Spain, and Sweden. Hospital performance was proxied using in-hospital risk-adjusted mortality. Multilevel Regression Modelling (MLRM) was used to assess differences in hospital performance, comparing the estimates of random intercept modelling (capturing hospital general contextual effects (GCE)), and random slope modelling (capturing hospital contextual effects for patients with and without congestive heart failure -CHF). The weighted Kappa Index (KI) was used to assess the agreement between performance estimates. Results We analysed 46,875 admissions of AMI, 6,314 with coexistent CHF, discharged from 107 hospitals. The overall in-hospital mortality rate was 5.2%, ranging from 4% in Sweden to 6.9% in Portugal. The MLRM with random slope outperformed the model with only random intercept, highlighting a much higher GCE in CHF patients [VPC = 8.34 (CI95% 4.94 to 13.03) and MOR = 1.69 (CI95% 1.62 to 2.21) vs. VPC = 3.9 (CI95% 2.4 to 5.9), MOR of 1.42 (CI95% 1.31 to 1.54) without CHF]. No agreement was observed between estimates [KI = -0,02 (CI95% -0,08 to 0.04]. Conclusions The different GCE in AMI patients with and without CHF, along with the lack of agreement in estimates, suggests that accounting for patient heterogeneity is required to adequately characterize and report on hospital performance.